Liang Chen

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 8

Top Topics

Induced Apoptosis

Multiple Myeloma

Top Venues

Cell cycle (Georgetown, Tex.)

Clinical and translational medicine

Clinical & translational immunology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Yan Zhu, Lukman O Afolabi, Xiaochun Wan, Joong Sup Shim, Liang Chen
TRIM family proteins: roles in proteostasis and neurodegenerative diseases. Open biology 12 (8) (2022)
Yanfeng Liu, Yingying Xu, Fan Wang, Yu Tong, Hongchang Li, Xiaochun Wan, Xiaolu Yang, Liang Chen
Inhibition of AMPK activity by TRIM11 facilitates cell survival of hepatocellular carcinoma under metabolic stress. Clinical and translational medicine 11 (12) (2022)
Xuejia Feng, Gui Yang, Litian Zhang, Shishi Tao, Joong Sup Shim, Liang Chen, Qingxia Wu
TRIM59 guards ER proteostasis and prevents Bortezomib-mediated colorectal cancer (CRC) cells' killing. Investigational new drugs 40 (6) (2022)
Jianchao Zhang, Xiaokai Fan, Lijuan Liao, Yan Zhu, Xiaochun Wan, Hai Rao, Liang Chen
TRIM28 attenuates Bortezomib sensitivity of hepatocellular carcinoma cells through enhanced proteasome expression. Clinical and translational medicine 12 (1) (2022)
Lukman O Afolabi, Mariam O Afolabi, Musbahu M Sani, Wahab O Okunowo, Dehong Yan, Liang Chen, Yaou Zhang, Xiaochun Wan
Exploiting the CRISPR-Cas9 gene-editing system for human cancers and immunotherapy. Clinical & translational immunology 10 (6) (2021)
Lijuan Liao, Deyu Duan, Yanfeng Liu, Liang Chen
LHPP inhibits hepatocellular carcinoma cell growth and metastasis. Cell cycle (Georgetown, Tex.) 19 (14) (2020)
Yanfeng Liu, Shishi Tao, Lijuan Liao, Yang Li, Hongchang Li, Zhihuan Li, Lilong Lin, Xiaochun Wan, Xiaolu Yang, Liang Chen
TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway. Nature communications 11 (1) (2020)
Liang Chen, Xiaolu Yang
TRIM11 cooperates with HSF1 to suppress the anti-tumor effect of proteotoxic stress drugs. Cell cycle (Georgetown, Tex.) 18 (1) (2018)